SI-BONE Achieves Near Universal U.S. Coverage for iFuse

SI-BONE reported 3Q21 orthopedic sales of $22.3 million, +9.4% vs. 3Q20. Third-quarter sales were a record high for the company. SI-BONE expects some acceleration in the fourth quarter for a full-year sales total in the range of $89 million to $90 million, representing growth of 21% to 23% vs. 2020.

According to the company's booking...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us